How Do I Know If Weight Loss Injections Are Right for Me
Cagrilintide efficacy for weight management in overweight and obesity was analyzed in phase 2 randomized, multi-center, double-blind, placebo-controlled, dose-finding clinical trial [113]
Only 4.2% of participants discontinued due to side effects after week 24, indicating that side effects become manageable or resolve entirely for the vast majority who continue treatment
S.BooneM
Studies utilizing Alzheimers disease models suggest that semaglutide treatment inhibits the activation of microglia and astrocytes, thereby reducing the release of pro-inflammatory mediators (Zhai et al., 2025)
It was a game changer. While vasomotor symptoms like hot flashes and night sweats are recurring topics in conversations about menopause, weight gain is just as pervasive: Around 60 percent of women gain weight during this transition, putting on an average of 1.5 pounds per year throughout their 40s and 50s